959641-51-1

Upstream product

• 345-29-9 4-fluorosalicylic acid 
• 392-04-1 methyl 4-fluoro-2-hydroxybenzoate 
• 1380495-46-4 methyl 4-fluoro-2-(2-methoxyethoxy)benzoate 
• 1380495-47-5 [4-fluoro-2-(2-methoxyethoxy)phenyl]methanol 

Downstream Products

• 1380495-49-7 [4-fluoro-2-(2-methoxyethoxy)phenyl]acetaldehyde 
• 1380495-50-0 2-[4-fluoro-2-(2-methoxyethoxy)phenyl]ethanol 
• 1380495-69-1 2-(1-{2-[4-fluoro-2-(2-methoxyethoxy)phenyl]ethyl}-piperidin-4-yl)-N-[(1R)-1-(4-fluorophenyl)-2-methylpropyl]-acetamide hydrochloride 
• 1380495-51-1 2-[4-fluoro-2-(2-methoxyethoxy)phenyl]ethyl 4-methylbenzenesulfonate 
• 1380495-48-6 4-fluoro-2-(2-methoxyethoxy)-1-(2-methoxyvinyl)benzene 

Relevant academic research and scientific papers

Synthesis and pharmacological evaluation of 2-(1-alkylpiperidin-4-yl)-N- [(1R)-1-(4-fluorophenyl)-2-methylpropyl]acetamide derivatives as novel antihypertensive agents

We synthesized and evaluated the inhibitory activity of a series of 2-(1-alkylpiperidin-4-yl)-N-[(1R)-1-(4-fluorophenyl)-2-methylpropyl]acetamide derivatives against T-type Ca2+ channels. Structure-activity relationship studies revealed that th